RETRACTION: Leukocyte cell-derived chemotaxin 2 affects nonalcoholic fatty liver disease

in Journal of Endocrinology
View More View Less
  • 1 Department of General Surgery, Jintan Affiliated Hospital of Jiangsu University, Jintan, Jiangsu, China
  • 2 Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
  • 3 Department of Geriatrics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China
  • 4 Medical School of Nantong University, Nantong, Jiangsu, China
  • 5 Department of Hepatology, Suzhou No. 5 People’s Hospital, Suzhou, Jiangsu, China

Correspondence should be addressed to J Zhu or Y Wang: zhujinzhou@suda.edu.cn or 18915543862@163.com

This article has been retracted by the journal. The retraction was made before the article reached its final form in the publication process. However, the authors’ accepted manuscript, prior to copy editing, page layout and proofing, was made available online as a Journal of Endocrinology Accepted Manuscript on 2 June 2020.

The article has been retracted because the Journal of Endocrinology was made aware, by the corresponding author J Zhu, of data manipulation and research misconduct, which affected the results and conclusions of the accepted manuscript ‘Leukocyte cell-derived chemotaxin 2 affects the development of nonalcoholic fatty liver disease’ on 26 June 2020. As such, and with agreement from all authors, the article has now been retracted. Bioscientifica will take no further action against the authors of the article.

This retraction was published 13 July 2020.

We apologise to our readers.

If the inline PDF is not rendering correctly, you can download the PDF file here.

 

      Society for Endocrinology